Elan to sell Westmeath unit to US firm, 400 jobs 'safe'

Athlone-based pharmaceutical company Elan is selling its Westmeath unit to US biotechnology firm Alkermes.

Athlone-based pharmaceutical company Elan is selling its Westmeath unit to US biotechnology firm Alkermes.

It is understood Elan will be retaining a 25% share in the business, which employs 400 staff in Athlone.

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited